LOUISVILLE, Ky., Jan. 12, 2018 /PRNewswire/ -- A recent data security incident affected patients receiving services fromOnco360 and CareMed Specialty Pharmacy. On November 14, 2017, suspicious activity involving an employee's email account was identified. Independent computer forensic experts were engaged to assist with the investigation.
Prompt measures were taken to address this incident, including changing email account passwords, providing additional training to employees on recognizing suspicious emails, implementing additional measures to further enhance e-mail security and reporting the incident to law enforcement. Although there is no indication that any of the information has been misused and even if risk of misuse may be low, as a precaution, affected individuals should carefully monitor their credit reports and billing statements for any unauthorized activity in the upcoming months. To help protect from any potential negative consequences from this incident, affected individuals are offered credit monitoring and identity protection services free of charge through ID Experts.
If you have any questions or would like to learn additional information, please call (800) 761-7902, a dedicated call center to answer any questions about the incident. The call center is available to answer questions Monday through Friday, between 8:00 a.m. and 8:00 p.m. EST. Onco360 and CareMed Specialty Pharmacy are subsidiaries of PharMerica. You may also submit any questions about this incident by mail directed to: Onco360/CareMed Specialty Pharmacy, Compliance Officer, 1901 Campus Place, Suite 100, Louisville, KY 40299.
View original content:http://www.prnewswire.com/news-releases/onco360-and-caremed-specialty-pharmacy-patients-notified-of-data-security-incident-300582137.html
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All